Childrens Pain and Fever

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the reduction of fever and the relief of minor aches and pains associated with various conditions, including the common cold, influenza, headache, sore throat, and toothache.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should advise patients to shake the product well before use. The appropriate dosage should be determined using the dosage chart provided, prioritizing weight for dosing when possible; otherwise, age may be used as a guide.

For patients weighing less than 24 pounds or under 2 years of age, it is recommended to consult a doctor before administration. For those weighing between 24 to 35 pounds or aged 2 to 3 years, the recommended dose is 5 mL (1 teaspoonful). For patients weighing 36 to 47 pounds or aged 4 to 5 years, the dosage increases to 7.5 mL (1 1/2 teaspoonfuls). Patients weighing 48 to 59 pounds or aged 6 to 8 years should receive 10 mL (2 teaspoonfuls). For those weighing 60 to 71 pounds or aged 9 to 10 years, the recommended dose is 12.5 mL (2 1/2 teaspoonfuls). Finally, for patients weighing 72 to 95 pounds or aged 11 years, the dosage is 15 mL.

Doses may be repeated every 4 hours as needed while symptoms persist, but should not be administered for more than 5 consecutive days unless directed by a physician. It is crucial to use only the enclosed dosing cup specifically designed for this product; other dosing devices should not be utilized.

Contraindications

Use of this product is contraindicated in the following situations:

Co-administration with any other drug containing acetaminophen, whether prescription or nonprescription, is prohibited due to the risk of acetaminophen overdose. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

Additionally, this product should not be used in patients with a known allergy to acetaminophen or any of the inactive ingredients contained in this formulation, as this may lead to severe allergic reactions.

Warnings and Precautions

Severe liver damage may occur in pediatric patients taking this product, which contains acetaminophen, if they exceed the maximum daily dosage of 5 doses within a 24-hour period or if they are concurrently using other medications that also contain acetaminophen. Healthcare professionals should monitor patients closely for adherence to dosing guidelines to mitigate the risk of hepatotoxicity.

Acetaminophen has been associated with severe skin reactions, which may manifest as skin reddening, blisters, or rash. In the event of any skin reaction, it is imperative to discontinue use immediately and seek medical assistance. Healthcare providers should educate patients and caregivers about the signs of potential allergic reactions to ensure prompt intervention.

In cases of severe sore throat that persists for more than 2 days, or if it is accompanied by additional symptoms such as fever, headache, rash, nausea, or vomiting, it is essential to consult a physician without delay. These symptoms may indicate a more serious underlying condition that requires further evaluation.

Healthcare professionals should advise patients to discontinue use and seek medical advice if any of the following occur: worsening pain lasting more than 5 days, fever that worsens or persists beyond 3 days, the emergence of new symptoms, or the presence of redness or swelling. These signs may indicate a serious medical condition that necessitates further investigation and management. Regular monitoring and patient education are crucial in ensuring safe use of this medication.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions.

Severe liver damage may occur in patients who exceed the maximum daily dosage of five doses within a 24-hour period or who take this product concurrently with other medications containing acetaminophen. It is crucial for patients to monitor their intake to avoid such risks.

Additionally, acetaminophen may lead to severe skin reactions, which can manifest as skin reddening, blisters, or rash. In the event of any skin reaction, patients are advised to discontinue use immediately and seek medical assistance.

Patients experiencing a severe sore throat that persists for more than two days, or is accompanied by fever, headache, rash, nausea, or vomiting, should consult a healthcare professional promptly.

Patients should also stop using the product and consult a doctor if pain worsens or lasts longer than five days, if fever worsens or lasts more than three days, if new symptoms arise, or if there is any redness or swelling, as these may indicate a serious condition.

It is recommended that patients with a history of liver disease consult a healthcare provider before using this product. Furthermore, patients taking the blood-thinning medication warfarin should seek advice from a doctor or pharmacist prior to use.

Drug Interactions

Patients should consult a healthcare professional prior to using acetaminophen if they are concurrently taking warfarin, a blood-thinning medication. The combination may lead to potential interactions that could affect the efficacy and safety of warfarin therapy.

No additional drug interactions or laboratory test interactions have been identified for acetaminophen. Therefore, routine monitoring or dosage adjustments are not specified beyond the aforementioned consideration with warfarin.

Packaging & NDC

Below are the non-prescription pack sizes of Childrens Pain and Fever (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 24 lbs (under 2 years) should consult a doctor for dosing recommendations. For children aged 2-3 years weighing 24-35 lbs, the recommended dose is 5 mL (1 tsp). For those aged 4-5 years weighing 36-47 lbs, the dose increases to 7.5 mL (1 1/2 tsp). Children aged 6-8 years weighing 48-59 lbs should receive 10 mL (2 tsp), while those aged 9-10 years weighing 60-71 lbs should be given 12.5 mL (2 1/2 tsp). For children aged 11 years weighing 72-95 lbs, the recommended dose is 15 mL. Dosing should ideally be based on weight; if weight is not available, age may be used as a guide.

Doses may be repeated every 4 hours as needed while symptoms persist, but should not be administered for more than 5 days unless directed by a healthcare professional.

Severe liver damage may occur if a child takes more than 5 doses in 24 hours or if used concurrently with other medications containing acetaminophen. There is an allergy alert for acetaminophen, which may cause severe skin reactions, including skin reddening, blisters, and rash. If any skin reaction occurs, use should be discontinued immediately, and medical assistance should be sought.

Parents should consult a doctor if their child has liver disease or is taking the blood-thinning medication warfarin. In the event of an overdose, immediate medical help should be sought, or a Poison Control Center should be contacted, as prompt attention is critical for both children and adults, even if no symptoms are apparent.

Additionally, if a sore throat is severe, persists for more than 2 days, or is accompanied by fever, headache, rash, nausea, or vomiting, a healthcare professional should be consulted promptly.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of acetaminophen during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare professional before use. While potential risks to the fetus are not clearly defined, caution is advised. There are no specific dosage modifications for pregnant individuals; therefore, it is essential to seek guidance from a healthcare provider regarding appropriate use. The decision to use acetaminophen during pregnancy should involve a discussion with a healthcare provider to carefully weigh the potential benefits against the risks.

Lactation

Lactating mothers should consult a doctor before using this product. There is a potential for excretion in breast milk, and caution is advised when administering this product to nursing mothers due to the potential risk to the infant.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment should be closely monitored when using this product, as it contains acetaminophen, which is associated with the risk of severe liver damage. It is critical to adhere to the recommended dosage guidelines to minimize the risk of hepatotoxicity.

Specifically, patients must not exceed 5 doses within a 24-hour period, as this represents the maximum daily amount. Additionally, caution is advised when administering this product in conjunction with other medications that also contain acetaminophen, as this may further increase the risk of liver damage.

Healthcare providers should evaluate liver function prior to initiating treatment and consider regular monitoring throughout the course of therapy, particularly in patients with known hepatic impairment. Adjustments to the dosing regimen may be necessary based on the severity of liver dysfunction and the patient's overall clinical status.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt medical intervention is crucial for both adults and children, even in the absence of observable signs or symptoms.

Healthcare professionals are advised to remain vigilant and proactive in managing potential overdose situations. The lack of immediate symptoms does not preclude the possibility of serious health risks, and therefore, timely evaluation and treatment are essential to mitigate any adverse effects.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

Postmarketing experience has identified that acetaminophen may be associated with severe skin reactions. Reports indicate that symptoms can include skin reddening, blisters, and rash. In the event of a skin reaction, it is advised to discontinue use immediately and seek medical assistance.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important to inform patients not to use this product in conjunction with any other medications that contain acetaminophen, whether prescription or nonprescription. If patients are uncertain about the presence of acetaminophen in other medications, they should be encouraged to consult a doctor or pharmacist for clarification.

Patients should be cautioned against using this product if their child has a known allergy to acetaminophen or any of the inactive ingredients contained in the formulation. Healthcare providers should instruct patients to discontinue use and seek medical advice if the child's pain worsens or persists for more than five days, or if a fever worsens or lasts longer than three days. Additionally, patients should be advised to stop use and consult a doctor if new symptoms arise or if there is any redness or swelling, as these may indicate a serious condition.

It is essential to emphasize that patients must not exceed the recommended dosage of this product, and they should be made aware of the potential risks associated with overdose. Healthcare providers should also recommend that patients consult a doctor if their child has liver disease or if they are taking the anticoagulant medication warfarin before using this product.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a controlled temperature range of 20-25°C to maintain its integrity and efficacy. Proper storage conditions should be ensured to prevent exposure to extreme temperatures or environmental factors that may compromise the product's quality.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Childrens Pain and Fever, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)